Prof. Dr. Jun-Jun Yeh | Data Analysis | Best Researcher Award
Prof. Dr. Jun-Jun Yeh, professor, ditmanson medical fondation, Taiwan.
Dr. Jun-Jun Yeh is a renowned Taiwanese physician and researcher with over 25 years of experience in pulmonary medicine and family medicine. He has held significant roles at China Medical University, Chung Gang Memorial Hospital, Pingtung Christian Hospital, and National Taiwan University Hospital. Currently, he is the Chief of Family Medicine and Attending Chest Physician at Ditmanson Medical Foundation Chia-Yi Christian Hospital and Professor at Chia Nan University of Pharmacy and Science. Widely recognized for his contributions, he has been featured in multiple editions of Marquis Who’s Who and holds leading positions in international medical societies.
Publication Profile
🎓 Education Background
Dr. Yeh holds a Master’s degree in both pulmonary medicine and family medicine. His academic journey reflects a strong foundation in medical science and clinical practice, enabling him to specialize in respiratory conditions and chronic diseases. He has supplemented his formal education with continuous affiliations to leading organizations such as the American Thoracic Society and European Respiratory Society to stay updated with advancements in medicine. His dual-specialization has positioned him at the intersection of research and real-world healthcare application, allowing him to contribute substantially to both patient care and academic literature.
🏥 Professional Experience
Dr. Yeh began his medical career at China Medical University in Taichung, Taiwan, where he served for nearly 15 years. His professional trajectory then took him through appointments at Chung Gang Memorial Hospital, Pingtung Christian Hospital, and the prestigious National Taiwan University Hospital. Currently, he serves as Chief of Family Medicine and Chest Physician at Chia-Yi Christian Hospital and as a Professor at Chia Nan University. In addition to clinical responsibilities, he is an active peer reviewer and editorial chair for numerous international journals, significantly shaping the landscape of pulmonary and thoracic medicine.
🏆 Awards and Honors
Dr. Yeh has received numerous accolades over his career, including repeated listings in Who’s Who in the World and Who’s Who in Science and Engineering. He was honored with first place by the Korean Society of Thoracic Radiology from 2010 to 2012. His research has been cited in international guidelines, including those from the American College of Radiology. He is also ranked among the top global experts in pulmonary medicine according to Expertscape (2000–2018), reflecting his exceptional influence and contribution in areas such as thoracic imaging, pulmonary infection, and chronic respiratory disease.
🔬 Research Focus
Dr. Yeh’s research focuses on pulmonary medicine, specifically thoracic imaging, pulmonary infections, chronic obstructive pulmonary disease, asthma, and their intersections with metabolic syndromes like diabetes. His interests also extend to osteoporosis and dementia in respiratory patients. He has published extensively in high-impact journals such as European Radiology, European Respiratory Journal, Scientific Reports, and Journal of Clinical Medicine. His studies, including large cohort analyses, have had real-world implications, influencing clinical guidelines and therapeutic strategies across global healthcare systems.
🔚 Conclusion
Dr. Jun-Jun Yeh stands out as a globally respected leader in respiratory and internal medicine. With a career spanning academic, clinical, and editorial excellence, he continues to influence the fields of pulmonary care and interdisciplinary research. His dedication to clinical service, scholarly publishing, and international collaboration showcases his role as a thought leader and innovator in medical science. Dr. Yeh’s profound impact on global health is evident through his mentorship, publications, and active participation in advancing the field of cardio-metabolic-pulmonary medicine.
📚 Publications
-
Long-Term Impact of COVID-19 on Osteoporosis Risk Among Patients Aged ≥50 Years with New-Onset Overweight, Obesity, or Type 2 Diabetes
Year: 2025 | Medicina | Cited by: – -
Relationship between GLP-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes
Year: 2024 | Biomedicines | Cited by: 10+ articles -
Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay
Year: 2022 | Biomedicines | Cited by: 25+ articles -
Time-dependent propensity-matched general population study of the effects of statin use on cancer risk
Year: 2021 | BMJ Open | Cited by: 30+ articles -
Effects of statins and steroids on coronary artery disease and stroke in patients with ILD
Year: 2021 | PLOS ONE | Cited by: 35+ articles -
Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?
Year: 2021 | European Heart Journal | Cited by: 100+ articles -
Predictors of Initial Smear-Negative Active Pulmonary Tuberculosis…
Year: 2019 | Scientific Reports | Cited by: 45+ articles -
Statin for Tuberculosis and Pneumonia in Patients with ACOS
Year: 2018 | Journal of Clinical Medicine | Cited by: 60+ articles